Bioplus Acquisition (BIOS) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bioplus Acquisition Corp   (NASDAQ: BIOS)


Bioplus Acquisition 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Bioplus Acquisition 's ROA in the second quarter of 2023?
Bioplus Acquisition Corp achieved a return on average assets (ROA) of 2.72 % in its second quarter of 2023, this is above BIOS's average return on assets of 1.83%.
Bioplus Acquisition Corp assets over the 12 months ending in its second quarter of 2023 are valued at $213 million

Despite the company's net income deteriorating, Bioplus Acquisition was able to improve its ROA compared to the first quarter of 2023.

However, within the Healthcare sector 172 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2023 quarter, so far to 1794, from total ROA ranking in the first quarter of 2023 at 2078.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Total Assets Change -41.39 % 1.98 % 17269.33 % - -
Y / Y Net Income Change 4877.92 % - - - -
Net Income (TTM) in million 6 5 2 0 0
Return On Assets (TTM) 2.72 % 1.93 % 0.84 % 0.24 % -0.2 %
BIOS's Total Ranking # 1794 # 2078 # 3029 # #
Total Assets (TTM) in million 138 240 238 237 236
Seq. Total Assets Change -42.53 % 0.89 % 0.77 % 0.3 % 0.01 %
Seq. Net Income Change -46.56 % 47.51 % 138.75 % 2544.88 % -

BIOS's 5 Years Annual ROA >> Back to BIOS Management Effectiveness >> Compare BIOS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 53
Sector # 173
Overall # 1767

Return On Assets Statistics
High Average Low
2.71 %
1.83 %
0.84 %
(Jun 30 2023)   (Dec 31 2022)





Financial Statements
Bioplus Acquisition 's Assets $ 138 million BIOS's Balance sheet
Bioplus Acquisition 's Income $ 1 million Quarterly BIOS's Income Statement
BIOS's Income by Division See BIOS's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
FY
FY
FY
FY
Y / Y Total Assets Change - - - - -
Total Assets in million 238 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million 2 0 0 0 0
Annual Return On Assets 0.84 % - - - -

BIOS's 5 Years Annual ROA >> Back to BIOS Management Effectiveness >> Compare BIOS ROA to its Competitors



Comment on BIOS's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA deteriorated to 0.84 %, despite annual net income growth of % to $2.00 million, from $0.00 million a year ago, as BIOS's assets increase to $238.32 million, by %.


More Return On Assets Ratios
BIOS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BIOS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BIOS's Competitors
Subscribers only: Roa for Bioplus Acquisition 's Suppliers
Subscribers only: Return On Assets for BIOS's Customers

You may also want to know
BIOS's Roi BIOS's Inventory Turnover Ratio BIOS's Growth Rates BIOS's Dividend Comparisons
BIOS's Profitability Ratios BIOS's Asset Turnover Ratio BIOS's Dividend Growth
BIOS's Roe BIOS's Valuation Ratios BIOS's Financial Strength Ratios BIOS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA
Electromed Inc   7.44 %
Neurocrine Biosciences Inc   7.44 %
Patterson Companies Inc   7.37 %
Stryker Corp  7.37 %
Encompass Health Corporation  7.31 %
Haemonetics Corporation  7.17 %
Abbott Laboratories  7.01 %
Organon and Co   6.99 %
Johnson and Johnson  6.96 %
Ensign Group Inc  6.63 %
Quest Diagnostics Inc  6.56 %
Charles River Laboratories International inc   6.44 %
Abbvie Inc   6.32 %
Dexcom Inc   6.32 %
Incyte Corporation  6.28 %
Glucotrack Inc   6.11 %
Fonar Corporation  6.10 %
Staar Surgical Co  5.96 %
Lftd Partners Inc   5.93 %
Viemed Healthcare Inc   5.75 %
Addus Homecare Corp  5.75 %
Henry Schein Inc   5.61 %
Acadia Healthcare Company Inc   5.49 %
Redwoods Acquisition Corp  5.41 %
Teleflex Incorporated  5.36 %
Merit Medical Systems Inc  5.26 %
Align Technology inc   5.26 %
Hologic Inc  5.21 %
Healthcare Services Group Inc   5.17 %
Alkermes Plc   5.14 %

Date modified: 2026-06-22T16:30:31+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.